Clinical, pharmacologic, and pathologic findings presented are those in a 12-year-old boy with primary pulmonary hypertension associated with medial hypertrophy of the pulmonary muscular arteries and arterioles.
Acetylcholine
Tolazoline Isoproterenol CINCE Romberg's description in 18911 of a a case of primary pulmonary hypertension, numerous examples of this condition have been reported. From this background, the concept has evolved that primary pulmonary hypertension is a progressive, fatal condition, unresponsive to therapeutic attempts, and related to fixed pulmonary vascular changes. In a few patients, however, administration of certain drugs has been followed by a decrease in pulmonary vascular resistance and pressure (table 1) . The primary purpose of this report is to describe the case of a 12-year-old boy with primary pulmonary hypertension in whom isoproterenol, tolazoline (Priscoline), and acetylcholine each resulted in a three to fourfold decrease in total pulmonary vascular resistance. After the patient died from an unfortunate complication, necropsy showed From Intrapulmonary arterial drug therapy the principal structural abnormality of the pulmonary arterial vessels to be medial hypertrophy, a process which suggests the potential of vasodilatation.
Report of Case Clinical Features
A 12-year-old boy, on admission to the University of Minnesota Hospitals, presented a history of well-being until 2 years earlier when dizzy spells, syncope, headaches, and chest pain began. Initially, these symptoms were considered to have resulted from an automobile accident in which the boy had been rendered temporarily unconscious. Neurologic examination following the accident failed to reveal any abnormality. Because of the symptoms named and the development of dyspnea on exertion, the patient was referred for evaluation. The family history was negative for collagen disease and pulmonary hypertension.
Physical examination revealed a slender, acyanotic, white boy in no apparent distress. The body weight was 74 pounds and the height was 58 inches. The brachial blood pressure was 92 mm Hg, systolic, and 55, diastolic, and the pulse rate was 70 beats/min. Slight cardiomegaly was associated with a diffuse left parasternal heave. While the first cardiac sound was normal, the pulmonic component of the second sound was markedly accentuated and no murmur was present. The liver was enlarged, its lower edge lying 2 cm below the right costal margin. There was no Scintiscan of the brain gave negative results, and the electroencephalogram was mildly abnormal but without focal abnormalities.
On the basis of the clinical analysis, a presumptive diagnosis of primary pulmonary hypertension was made, and cardiac catheterization was performed. This study showed severe pulmonary hypertension with a pulmonary arterial pressure at rest of 82/45 and an electronically meaned pressure of 60 mm Hg. Simultaneously determined systemic arterial pressure was 120/80, with a mean of 94 mm Hg. The pulmonary "arterial wedge" pressure was normal, the mean being 7 mm Hg. There was no evidence of any shunt. The right atrial pressure was normal (mean 6 mm Hg). The levels of systemic arterial blood gases were: Po2, 81.6 mm Hg; Pco2, 31 mm Hg; and pH, 7.42. These findings were considered to exclude veno-arterial shunting, obstructive pulmonary disease, and hypoxic pulmonary hypertension related to hypoventilation. Failure of the pulmonary arterial pressure to change during inhalation of 100% oxygen further excluded hypoxia as a basis for the pulmonary hypertension. Simultaneous analysis of alveolar gas (end expiration) and of arterial blood gasses revealed no alveolararterial gradient of Pco2, thereby excluding any major ventilation-perfusion defects. Right ventriculography showed a large right ventricular cavity, massively dilated pulmonary arteries, and marked attenuation of the peripheral pulmonary vasculature. There was no evidence for the presence of gross pulmonary emboli.
The findings of the cardiac catheterization, therefore, strongly favored primary pulmonary hypertension, although multiple microscopically sized pulmonary emboli could not be excluded. To study the reactivity of the pulmonary vascular bed, hemodynamic measurements were made during exercise and during infusion of pharmacologic agents. The results are summarized in figure 1 . At rest, the cardiac output was at the lower limits of normal and the pulmonary arterial pressure elevated, indicating a high degree of pulmonary vascular resistance. Inhalation of 100% oxygen at rest showed no significant change in any of the measured parameters.
Development of fatigue limited the amount of exercise possible. With exercise, the systemic blood pressure and cardiac output increased only slightly, while the pulmonary arterial pressure rose to nearly equal the systemic pressure. Infu- 
Pathologic Features
Pertinenit findings at n-eciropsy were lirnited to the heart and lungs. The heart was einlarged (330 g) on the basis of a markedly dilated and hypertrophied right ventricle. The latter measured 0.8 cm in thiickiness. The left ventricular thickness was 1.4 cm. There was a small sutLred perforationl of thlie anteriior wall of the right ventricular outflow tract just below the pulmonary valve. The by guest on April 13, 2017 http://circ.ahajournals.org/
Downloaded from
The structure of the media of the pulmonary trunk resembled that of the aorta. This suggests strongly that the pulmonary hypertension had been present from birth.14 The significance of the clinical studies are that administration of certain drugs (acetylcholine, Priscoline, and isoproterenol) resulted in a fall in pulmonary arterial pressure. It was of practical importance, however, that high dosage and intrapulmonary arterial administration were required to achieve the desired effect. It is, as yet, unknown whether longterm intrapulmonary arterial administration would have (1) continued to be effective or (2) been followed by a break in the factor which led to the pulmonary arterial vasoconstriction responsible for the pulmonary hypertension. In our study, the complication of perforation of the right ventricle by the indwelling catheter terminated the life of the patient and therefore precluded the long-term study desired.
Review of the literature indicates that several drugs have been tested for hemodynamic response in primary pulmonary hypertension. The results of these studies are summarized in table 1 . It is evident that, of the four drugs used, each by short-term intravenous or intrapulmonary arterial administration, tolazoline or acetylocholine were tried more than the other two drugs, namely, hexamethonium and isoproterenol. According to these reports, varying results were obtained with each of the two major drugs, although more commonly a favorable hemodynamic response was obtained than an equivocal or negative one.
